Quarles & Brady's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
- Penetration Testing In Healthcare: HIPAA And GDPR Requirements
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
eConsent: The Missing Ingredient To More Engaging Clinical Trials
Electronic consent promotes better trial experiences, but many sites and sponsors are wary of giving up paper-based processes. Consider their reasons for caution and how teams can prepare for the switch.
-
Myth Or Fact: The Future Of Electronic Data Capture
Explore how EDC platforms are empowering researchers to conduct efficient trials regardless of data volume, source diversity, or patient demographics.
-
Growing Pains: The Real Story Behind Gen AI Development In Clinical Trial Ops
As Gen AI develops and reaches advanced stages it introduces risks such as model hallucinations, which can affect trial accuracy and reliability. Explore how to address these challenges.
-
Streamlining Clinical Supply With Advanced Automation
Clinical trials are the backbone of pharmaceutical advancements, but they come with their own set of challenges, particularly in data management and supply chain logistics.
-
Placebo Response In Clinical Trials: Challenges And Mitigation Strategies
Placebo response can impact clinical trial outcomes. Signant Health offers solutions such as eCOA, and tailored training to mitigate these effects and ensure reliable, accurate results.
-
Paving The Way For Virtual Trials In Neurology: A Fully Remote ALS Study
The COVID-19 pandemic has completely changed the way we think about clinical research and care. Clinical trials, a vital component of the drug development process, were heavily disrupted because patients, often with weakened immune systems, could not visit hospitals and research sites.
-
eCOA Solution Design Recommendations: Applied Insights From Trial Sites, CRAs
Enhance hybrid trials with digitalization through remote data capture using smartphones, tablets, and computers, improving participant experience and data integrity.
-
IRT: A New Approach To Meeting The Needs Of Early Phase Trials
As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
Driving Fundamentals: Ensuring An Efficient Clinical Research Process
Gain insight into drawing constant parallels to clinical research teams and how easy it is for anyone executing the same processes every day to take the fundamentals for granted.
-
How Health Information Technology Is Transforming Human Lives
Here, the authors take a closer look at how these advancements are not just revolutionizing healthcare but also instilling hope for a brighter and healthier future.